Skip to content

Jazz Pharmaceuticals

US · JAZZ #1123 by market cap Listed 1970
230.26 -6.19 -2.62%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Quant vs Street three independent views, side by side

StockVane factor grade
B-
Momentum strategy signal
Hold
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

✦ Quant Analyst Revision Trend how this is computed

Mixed
1
■ Upgrades■ Downgrades
  • 1 upgrade vs 0 downgrades among tracked analyst rating changes.
  • Most recent: UBS moved from Hold to Buy on 2026-05-19.

Analyst consensus 16 analysts

Buy
Avg price target 307.13 +33.4%
Price target rangecurrent 230.26
Low275.00
Avg307.13
High337.00
Buy 100% Hold 0% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-16 Needham -- Buy 308.00
2026-11-13 UBS -- Buy 326.00
2026-11-13 Morgan Stanley -- Buy 324.00
2026-11-12 Piper Sandler -- Buy 330.00
2026-11-03 TD Cowen -- Buy 300.00
2026-11-03 CCORF -- Buy 300.00
2026-11-03 Wells Fargo -- Buy 300.00
2026-11-03 Piper Sandler -- Buy 310.00
2026-11-03 Morgan Stanley -- Buy 319.00
2026-11-03 Stifel -- Buy 275.00
2026-11-03 Barclays -- Buy 275.00
2026-11-03 RBC Capital -- Buy 305.00
2026-11-03 J.P. Morgan -- Buy 310.00
2026-11-02 Wells Fargo -- Buy 300.00
2026-11-02 BofA Securities -- Buy 313.00
2026-11-02 Morgan Stanley -- Buy 314.00
2026-11-02 Citi -- Buy 325.00
2026-10-28 UBS -- Buy 337.00
2026-10-28 J.P. Morgan -- Buy 300.00
2026-10-27 Citi -- Buy 325.00
2026-10-21 Morgan Stanley -- Buy 314.00
2026-10-16 Needham -- Buy 310.00
2026-10-15 Citi -- Buy 325.00
2026-10-13 Barclays -- Buy 271.00
2026-10-09 BofA Securities -- Buy 313.00

Price target trend monthly average, last 3 years

Recent rating changes

DateFirmChangeTarget
2026-05-19 UBS Hold → Buy 307.00

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-11-02 After close ±7.69% +7.13% (in line)
2026/Q2 2026-08-03 After close ±6.48% +3.99% (in line)
2026/Q1 2026-05-05 After close ±6.19% +7.68% (beat)
2025/Q4 2026-02-24 After close ±7.84% +13.23% (beat)
2025/Q3 2025-11-05 After close ±7.81% -2.31% (in line)
2025/Q2 2025-08-05 After close ±10.58% -6.42% (in line)
2025/Q1 2025-05-06 After close ±11.47% -8.75% (in line)
2024/Q4 2025-02-25 After close ±8.47% +3.22% (in line)
2024/Q3 2024-11-06 After close ±7.79% +6.75% (in line)
2024/Q2 2024-07-31 After close ±9.90% +3.75% (in line)
2024/Q1 2024-05-01 After close ±8.33% -0.92% (in line)
2023/Q4 2024-02-28 After close ±8.73% -8.33% (in line)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 20:02:26 · For reference only, not investment advice and not tailored to your situation.

Jazz Pharmaceuticals discussion 0 comments

Add a comment